Ovarian cancer
Conditions
Interventions
Sponsors
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
Female
Age
10 Years to 82 Years
Inclusion criteria
Inclusion criteria: 1.Patients willing to participate as evidenced by signing the written informed consent form; 2.Patients enrolled before initiation of any kind of treatment (including but not limited to adnexal mass excision surgery, chemotherapy, target therapy); 3.Patients with adnexal lesions had pathological diagnosis after enrollment; 4.had no history of malignancy other than ovarian cancer.
Exclusion criteria
Exclusion criteria: 1.Participants unwilling to cooperate or participate in other clinical trials; 2.Participants with any underlying disease that affects platelet production and apoptosis; 3.Participants with history of malignancy other than ovarian cancer; 4.Patients with unqualified platelet samples [low quality (RNA integrity number < 7) or quantity (< 10 picogram) of total RNA].
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| accuracy;Sensitivity;specificity;Area Under The Curve;positive predictive value; | — |
Countries
China
Contacts
Public ContactGao Qinglei
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed